Stuart McMillan MSP is supporting Breast Cancer Now Scotland’s campaign demanding that Perjeta, a cancer drug, be made available to women in Scotland living with incurable breast cancer.
The Greenock and Inverclyde MSP has written to the General Manager at Roche, the manufacturer of Perjeta, as well as the Director of the NHS’s National Procurement department. Scottish Government officials have met with the manufacturer, Roche, who have also held discussions with the NHS.
The local SNP MSP is supporting Breast Cancer Now Scotland’s campaign to further raise awareness of the injustice breast cancer sufferers living in Scotland are subjected to, but also to spark dialogue to urge Roche to bring forward a new submission to the Scottish Medicines Consortium (SMC) for their consideration at a price that is fair, transparent and represents best value.
Speaking on the subject, Mr McMillan said:
“I have expressed my deepest concerns that women with incurable breast cancer in Scotland are being denied more time to live simply because they cannot access Perjeta.
“Perjeta is a life-saving drug that is available in England and Wales, and its time women living in Scotland are privy to this standard of care too. This is why I’m proudly supporting Breast Cancer Now Scotland’s campaign.
“I hope my, and other MSPs’, support for this campaign will highlight the importance of Perjeta being made available to women in Scotland now, despite the decisions made by the Scottish Medicines Consortium being independent of Ministers and Parliament.
“It’s still right that I highlight the urgency with which this drug is required in Scotland.”